Medical Devices & Technology

WASHINGTON, 4 March 2026: AdvaMed said the U.S. Senate has approved legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, and the association called on the House of Representatives to move quickly on passage. The medtech trade group said the vote matters because authorization for the two programs lapsed on 30 September 2025, leaving early-stage medical technology companies without the certainty they need as they pursue product research and development.

SHERIDAN, WYOMING - March 31, 2026 - Early-stage medtech companies could regain a key non-dilutive funding route in 2026 after the Senate passed legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, reducing uncertainty that has persisted since the programs' authorization lapsed on September 30, 2025. AdvaMed said the Senate action restores momentum for grants that support early research and development at startups and small manufacturers, and it urged the House of Representatives to move quickly on passage. The association framed the programs as an important bridge for companies that struggle to finance next-generation device development before products reach patients or later-stage commercial milestones.

SHERIDAN, WYOMING - December 16, 2025 - Advita Ortho has been recognized with an Innovation award in the 2025 Medical Device Network Excellence Awards for its Newton® Balancing Technology, highlighting the growing clinical and commercial demand for more data-driven, reproducible approaches to soft-tissue management in total knee replacement surgery.

Award recognition spotlights soft-tissue balancing as a key outcomes lever
While implant design and alignment remain central to knee arthroplasty performance, soft-tissue balancing is increasingly viewed as a differentiator in patient satisfaction and functional outcomes. Advita Ortho is positioning Newton as a method to bring greater consistency to what has often been a highly surgeon-dependent step-an area the company notes has historically contributed to dissatisfaction in a meaningful share of procedures.

SHERIDAN, WYOMING - December 10, 2025 - Implantica is strengthening its European market expansion for RefluxStop®, announcing that Florence's renowned Careggi University Hospital has performed its first procedure with the implantable device for gastroesophageal reflux disease (GERD), adding another high-profile reference center to the therapy's growing footprint.

Careggi University Hospital Becomes a Flagship Center for GERD Innovation

The first RefluxStop® implantation at Careggi University Hospital was carried out by Dr. Paolo Prosperi, Chief of Emergency Surgery, assisted by Dr. Alessio Giordano. As part of the University of Florence, Careggi is one of Italy's most respected academic medical centers and a key reference institution for advanced surgical technologies.

SHERIDAN, WYOMING - November 25, 2025 - Royal Philips is introducing DeviceGuide, an AI-powered device tracking solution that brings real-time, 3D navigation support into one of interventional cardiology's most demanding procedures: minimally invasive repair of leaking heart valves. Built on the company's EchoNavigator platform and previewed at London Valves 2025, DeviceGuide is designed to translate complex imaging into intuitive visual guidance, helping structural heart teams perform mitral valve repair with greater clarity, confidence and reproducibility.

AI-guided navigation inside the procedure room

SHERIDAN, WYOMING - November 14, 2025 - Rapid prototyping and digital on-demand manufacturing are becoming indispensable pillars in the medical device industry as manufacturers race to accelerate development cycles, reduce costs, and bring high-performance devices to market faster. With rising demand for personalized medical solutions and increasingly complex regulatory expectations, companies are turning to advanced prototyping partners to validate designs earlier, improve manufacturability, and support real-world clinical readiness.

Bolded H5 subheadings start below

Innovation Driving Faster Medical Device Development

SHERIDAN, WYOMING - November 13, 2025 - Researchers at the University of Tsukuba have presented the first-ever brain-imaging evidence that a wearable cyborg can directly activate neuroplasticity through intentional movement. The study, centered on the Hybrid Assistive Limb (HAL), shows that users' voluntary intention to move triggers significant activity in the brain's higher motor areas-advancing the understanding of how robotics can support neural recovery and rehabilitation.

Proving Human-Machine Synergy Through Brain Imaging

SHERIDAN, WYOMING - November 13, 2025 - The upcoming 13th MEDICA MEDICINE + SPORTS CONFERENCE (MMSC), set to take place from November 19-20 at the Congress Center Düsseldorf (CCD Süd), is shaping up to be a global hub for innovation in sports and health. Part of the renowned MEDICA trade fair, the conference will unite leading sports physicians, scientists, technologists, and health professionals to explore how data, technology, and science are redefining performance and longevity.

Science-Based Innovation for Prevention and Regeneration
Now in its thirteenth year, the MMSC has evolved into one of Europe's premier interdisciplinary platforms for health and sports professionals. The 2025 program will spotlight emerging research and practical applications in prevention, regeneration, and rehabilitation - from evidence-based diagnostics in elite sports to digital health tools for everyday fitness.

SHERIDAN, WYOMING - November 13, 2025 - The world's leading trade fairs for medical technology and healthcare innovation, MEDICA 2025 and COMPAMED 2025, will return to Düsseldorf from November 17-20, bringing together more than 5,300 exhibitors from 70 nations. This year's edition arrives at a pivotal time for the global medtech sector, as artificial intelligence, robotics, and connected care redefine healthcare delivery-while supply chain volatility, regulatory change, and labor shortages continue to test resilience across markets.

Shaping the Future of Healthcare Transformation

SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. has announced a significant leadership transition, positioning its executive team for continued strategic growth in the musculoskeletal technology sector. Effective July 18, 2025, Keith Pfeil assumed the role of President and Chief Executive Officer, succeeding Daniel Scavilla, who stepped down to pursue another opportunity. Additionally, Kyle Kline was appointed Senior Vice President and Chief Financial Officer.

Leadership Shifts Focused on Strategic Growth